Call for transparency in Covaxin clinical trials
The Hindu
Bharat Biotech failed to publish results in peer-reviewed journals
The World Health Organization’s (WHO) refusal to grant Emergency Use Listing (EUL) for ICMR-Bharat Biotech’s Covaxin vaccine is a setback for the country’s vaccination programme.
Indians travelling abroad with Covaxin shots are also finding it difficult to obtain visas or entry into other countries which generally recognise only WHO-approved vaccines.
While the WHO has asked the company for more details, it is felt that the lack of transparency and public accountability has led to such a situation.
More Related News